Last updated on December 2018

Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy


Brief description of study

The purpose of this study is to determine whether patients undergoing coronary intervention that also require oral anticoagulation, treatment with the COBRA PzF stent plus 14-day dual anti-platelet therapy (DAPT) has higher safety and non-inferior outcomes for thrombo-embolic events than compared with standard FDA-approved drug eluting stent (DES) plus 3 or 6-month DAPT.

Clinical Study Identifier: NCT02594501

Contact Investigators or Research Sites near you

Start Over

North Ohio Heart Center

Elyria, OH United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.